Diet in phenylketonuria: How long?

Annals of Nutrition and Metabolism

Volumn 42, Issue 2, 1998, Pages 63-67

  Endres, W ^a,b  

^a ST ANNA CHILDREN S HOSPITAL   (Austria)

^b Univ Klin Kinder Jugendheikunde   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; MYELIN; PHENYLALANINE;

DIET THERAPY; HEALTH CARE POLICY; HUMAN; HYPERPHENYLALANINEMIA; MEDICAL DECISION MAKING; PHENYLKETONURIA; PRIORITY JOURNAL; REVIEW;

DIET, PROTEIN-RESTRICTED; HUMANS; PHENYLALANINE; PHENYLKETONURIAS; PRACTICE GUIDELINES; TIME FACTORS;

EID: 0031922219     PISSN: 02506807     EISSN: None     Source Type: Journal    
DOI: 10.1159/000012719     Document Type: Review

References (40)

1. Bickel H, Gerrard J, Hickmans EM: Influence of phenylalanine intake on phenylketonuria. Lancet 1953; ii:812.
2. Bickel H, Gerrard J, Hickmans EM: The influence of phenylalanine intake on the chemistry and behaviour of a phenylketonuric child. Acta Paediatr 1954;43:64-77.
3. Johnson CF: What is the best age to discontinue the low phenylalanine diet in phenylketonuria? Clin Pediatr 1972;11:148-156.
4. Holtzman NA, Welcher DW, Mellits ED: Termination of restricted diet in children with phenylketonuria: A randomized controlled study. N Engl J Med 1975;293:1121-1124.
5. Saudubray JM, Rey F, Ogier H, Adabie V, Farriaux JP, Ghisolfi J, Guibaud P, Rey J, Vidailhet M: Intellectual and school performance in early-treated classical PKU patients. The French Collaborative Study. Eur J Pediatr 1987;146(suppl 1): A20-A22.
6. Rey F, Abadie V, Plainguet, Rey J: Long-term follow-up of patients with classical phenylketonuria after diet relaxation at 5 years of age. The Paris Study. Eur J Pediatr 1996; 155(suppl 1):39-44.
7. Anonymous: The duration of treatment of phenylketonuria. Lancet 1974;i:971-972.
8. Cabalska B, Duczynska N, Borzymowska J, Zorska K, Koslacz-Folga A, Bozkowa K: Termination of dietary treatment in phenylketonuria. Eur J Pediatr 1977;126:253-262.
9. Smith I, Lobascher ME, Stevenson JE, Wolff OH, Schmidt H, Grubel-Kaiser S, Bickel H: Effect of stopping low-phenylalanine diet on intellectual progress of children with phenylketonuria. Br Med J 1978;ii-723-726.
10. Brunner RL, Jordan MM, Berry HK: Early-treated phenylketonuria; neuropsychologic consequences. J Pediatr 1983;102:831-835.
11. Pennington BF, Doorninck WJ van, McCabe LL, McCabe RB: Neuropsychological deficits in early treated phenylketonuric children. Am J Ment Defic 1985;89:467-474.
12. Seashore MR, Friedman EG, Norelli RA, Bapat V: Loss of intellectual function in children with phenylketonuria after relaxation of dietary phenylalaline restriction. Pediatrics 1985;75:226-232.
13. Holtzman NA, Kronmal RA, Doorninck W van, Azen C, Koch R: Effect of age at loss of dietary control on intellectual performance and behavior of children with phenylketonuria. N Engl J Med 1986;314:593-598.
14. Koch R, Azen CG, Hurst N, Gross Friedman E, Fishier K: The effects of diet discontinuation in children with phenylketonuria. Eur J Pediatr 1987;146(suppl 1):A12-A16.
15. Naughten ER, Kiely B, Saul I, Murphy D: Phenylketonuria: outcome and problems in a 'diet-for-life' clinic. Eur J Pediatr 1987;146(suppl 1):A23-A24.
16. Schmidt H, Mahle M, Michel U, Pietz J: Continuation vs. discontinuation of low-phenylalanine diet in PKU adolescents. Eur J Pediatr 1987;146(suppl 1):A17-A19.
17. Michals K, Azen C, Acosta P, Koch R, Matalon R: Blood phenylalanine levels and intelligence of 10-year-old children with PKU in the National Collaborative Study. J Am Diet Assoc 1988;88:1226-1229.
18. Pietz J, Benninger Ch, Schmidt H, Scheffner D, Bickel H: Long-term development of intelligence (IQ) and EEG in 34 children with phenylketonuria treated early. Eur J Pediatr 1988;147:361-367.
19. Slijper FME, Huisman J, Hendrikx MMT, Kalverboer AF, Schot L v d: The effects of diet discontinuation in children with phenylketonuria. Eur J Pediatr 1988;147:445.
20. Smith I, Beasley MG, Ades AE: Effect on intelligence of relaxing the low phenylalanine diet in phenylketonuria. Arch Dis Child 1990;65: 311-316.
21. Smith I, Beasley MG, Ades AE: Intelligence and quality of dietary treatment in phenylketonuria. Arch Dis Child 1990;65:472-478.
22. Zwiauer K, Widhalm K, Scheibenreiter S, Knoll E: Longterm intellectual development in 86 children with phenylketonuria (PKU). Pediatr Res 1990;28:289.
23. Anonymous: Phenylketonuria grows up. Lancet 1991;337:1256-1257.
24. Azen CG, Koch R, Gross Friedman E, Berlow S, Coldwell J, Krause W, Matalon R, McCabe E, O'Flynn M, Peterson R, Rouse B, Scott CR, Sigman B, Valle D, Warner R: Intellectual development in 12-year-old children treated for phenylketonuria. Am J Dis Child 1991;145:35-39.
25. Smith I, Beasley MG, Ades AE: Effect on intelligence of relaxing the low phenylalanine diet in phenylketonuria. Arch Dis Child 1991;66: 311-316.
26. Curtius H-Ch, Baerlocher K, Vollmin JA: Pathogenesis of phenylketonuria: Inhibition of dopa and catecholamine synthesis in patients with phenylketonuria. Clin Chim Acta 1972;42:235-239.
27. Curtius HCh, Wolfensberger M, Steinmann B, Redweik U, Siegfried J: Mass fragmentography of dopamine and 6-hydroxydopamine. Application to the determination of dopamine in human brain biopsies from the caudate nucleus. J Chromatogr 1974;99:529-540.
28. Hommes FA, Eller AG, Taylor EH: Turnover of the fast components of myelin and myelin proteins in experimental hyperphenylalaninaemia. Relevance to termination of dietary treatment in human phenylketonuria. J Inherit Metab Dis 1982;5: 21-27.
29. Taylor EH, Hommes FA: Effect of experimental hyperphenylalaninemia on myelin metabolism at later stages of brain development. Int J Neurosci 1983;20:217-228.
30. Taylor EH, Hommes FA, Stewart DE: Effect of experimental hyperphenylalaninemia on biogenic amine synthesis at later stages of brain development. Biochem Med 1983;29:307-317.
31. Fisch RO, Chang P-N, Weisberg S, Guldberg P, Güttler F, Tsai MY: Phenylketonuric patients decades after diet. J Inherit Metab Dis 1995; 18:347-353.
32. Azen C, Koch R, Friedman E, Wenz E, Fishler K: Summary of findings from the United States collaborative study of children treated for phenylketonuria. Eur J Pediatr 1996;155 (suppl 1):29-32.
33. Burgard P, Schmidt E, Rupp A, Schneider W, Bremer HJ: Intellectual development of the patients of the German collaborative study of children treated for phenylketonuria. Eur J Pediatr 1996;155(suppl 1): 33-38.
34. Cabalska MB, Nowaczewska I, Sendecka E, Zorska K: Longitudinal study on early diagnosis and treatment of phenylketonuria in Poland. Eur J Pediatr 1996;155(suppl 1):53-55.
35. Scheibenreiter S, Tiefenthaler M, Hinteregger V, Strobl W, Mühl A, Ewald A, Schadler M: Austrian report on longitudinal outcome in phenylketonuria. Eur J Pediatr 1996;155(suppl 1):45-49.
36. Schmidt E, Burgard P, Rupp A: Effects of concurrent phenylalanine levels on sustained attention and calculation speed in patients treated for phenylketonuria. Eur J Pediatr 1996;155(suppl 1):82-86.
37. Zeman J, Pijackova A, Behulova J, Urge O, Saligova D, Hyanek J: Intellectual and school performance in adolescents with phenylketonuria according to their dietary compliance. The Czech-Slovak collaborative study. Eur J Pediatr 1996; 155(suppl 1):56-58.
38. Burgard P, Rey F, Rupp A, Abadie V, Rey J: Neuropsychologic functions of early treated patients with phenylketonuria, on and off diet: Results of a cross-national and cross-sectional study. Pediatr Res 1997;41:368-374.
39. Burgard P, Rupp A, Konecki DS, Trefz FK, Schmidt H, Lichter-Konecki U: Phenylalanine hydroxylase genotypes, predicted residual enzyme activity and phenotypic parameters of diagnosis and treatment of phenylketonuria. Eur J Pediatr 1996;155(suppl 1):11-15.
40. Medical Research Council Working Party on Phenylketonuria: Recommendations on the dietary management of phenylketonuria. Arch Dis Child 1993;68:426-427.